Efficacy & Safety of Cannabidiol for Gastroparesis & Functional Dyspepsia

See also
Status	Clinical Trial	Phase
Terminated	`NCT03285308` - A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01	Phase 3
Completed	`NCT00733551` - Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.	Phase 1
Completed	`NCT01650714` - Endoscopic Full Thickness Biopsy, Gastric Wall.	N/A
Completed	`NCT01452815` - Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis	Phase 2
Completed	`NCT01039974` - GSK962040 Drug-drug Interaction Study With Ketoconazole	Phase 1
Terminated	`NCT04844190` - Use of EndoFLIP and Manometry Prior to G-POEM	N/A
Enrolling by invitation	`NCT06215547` - Medtronic Enterra II Neurostimulator	N/A
Completed	`NCT04026997` - A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis	Phase 2
Completed	`NCT00562848` - A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040	Phase 1
Enrolling by invitation	`NCT04207996` - Vagus Nerve Response in Gastroparesis Patients
Completed	`NCT04607304` - ABCA2 GIRMS Analytical Validation Clinical Performance Study	N/A
Recruiting	`NCT06068114` - Gastric Pathophysiology in Diabetes
Completed	`NCT03259841` - Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy
Active, not recruiting	`NCT04300127` - Pioglitazone for Idiopathic Gastroparesis	Early Phase 1
Recruiting	`NCT01696734` - Domperidone in Treating Patients With Gastrointestinal Disorders	Phase 3
Terminated	`NCT04635306` - 13C-Spirulina Nitrogen Content GEBT Study	N/A
Withdrawn	`NCT02420925` - Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis	N/A
Recruiting	`NCT00777439` - Domperidone for Refractory Gastrointestinal Disorders	N/A
Terminated	`NCT00760461` - Domperidone in Refractory Gastroparesis	Phase 2
Completed	`NCT00612014` - Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis	Phase 2

NCT number	NCT03941288
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	Phase 2
Start date	September 4, 2019
Completion date	February 23, 2023

Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms